Identification of a conserved universal Th epitope in HIV-1 reverse transcriptase that is processed and presented to HIV-specific CD4+ T cells by at least four unrelated HLA-DR molecules

Journal of Immunology

Volumn 162, Issue 1, 1999, Pages 152-160

  Van Der Burg, Sjoerd H ^a   Kwappenberg, Kitty M C ^a   Geluk, Annemieke ^a   Van Der Kruk, Marjolein ^a   Pontesilli, Oscar ^b   Hovenkamp, Egbert ^b   Franken, Kees L M C ^a   Van Meijgaarden, Krista E ^a   Drijfhout, Jan Wouter ^a   Ottenhoff, Tom H M ^a   Melief, Cornelis J M ^a   Offringa, Rienk ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; HLA DR ANTIGEN; RNA DIRECTED DNA POLYMERASE;

ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; ASIAN; CAUCASIAN; HELPER CELL; HLA TYPING; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RESISTANCE; NEGRO; PRIORITY JOURNAL; RACE DIFFERENCE; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; CD4-POSITIVE T-LYMPHOCYTES; CLONE CELLS; CONSERVED SEQUENCE; CYTOKINES; EPITOPES, T-LYMPHOCYTE; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HLA-DR ANTIGENS; HUMANS; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN BINDING; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0032910883     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Miedema, F. L. Meyaard, M. Koot, M. R. Klein, M. T. L. Roos, M. Groenink, R. A. M. Fouchier, A. B. van't Wout, M. Tersmette, P. T. A. Schellekens, et al. 1998. Changing virus-host interactions in the course of HIV-1 infection. Immunol. Rev. 140:35.
2. + T cell responses associated with control of viremia. Science 278:1447.
3. Rowland-Jones, S., J. Sutton, K. Ariyoshi, T. Dong, F. Gotch, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, and T. Corrah, 1995. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1:59.
4. Fowke, K. R., N. J. Nagelkerke, J. Kimani, J. N. Simonsen, A. O. Anzala, J. J. Bwayo, K. S. MacDonald, E. N. Ngugi, and F. A. Plummer. 1996. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 348:1347.
5. Clerici, M., A. V. Sison, J. A. Berzofsky, T. A. Rakusan, C. D. Brandt, M. Ellaurie, M. Villa, C. Colic. D. J. Venzon, and J. L. Sever. 1993. Cellular immune factors associated with mother-to-infant transmission of HIV. AIDS 7:1427.
6. Rowland-Jones, S. L., D. F. Nixon, M. C. Aldhous, F. Gotch, K. Ariyoshi, N. Hallam, J. S. Kroll, K. Froebel, and A. McMichael. 1993. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet 341:860.
7. De Maria, A., C. Cirillo, and L. Moretta. 1994. Occurrence of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T cell activity in apparently uninfected children born to HIV-1-infected mothers. J. Infect. Dis. 170:1296.
8. Cheynier, R., P. Langlade-Demoyen, M. R. Marescot, S. Blanche, G. Blondin, S. Wain-Hobson, C. Griscelli, E. Vilmer, and F. Plata. 1992. Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers. Eur. J. Immunol. 22:2211.
9. Clerici, M., J. M. Levin, H. A. Kessler, A. Harris, J. A. Berzofsky, A. L. Landay, and G. M. Shearer. 1994. HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood. JAMA 271:42.
10. Pinto, L. A., J. Sullivan, J. A. Berzofsky, M. Clerici, H. A. Kessler, A. L. Landay, and G. M. Shearer. 1995. ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. J. Clin. Invest. 96:867.
11. Furci, L., G. Scarlatti, S. Burastero, G. Tambussi, C. Colognesi, C. Quillent, R. Longhi, P. Loverro, B. Borgonovo, D. Gaffi, et al. 1997. Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele. J. Exp. Med. 186:455.
12. Mazzoli, S., D. Trabattoni, S. Lo Caputo, S. Piconi, C. Ble, F. Meacci, S. Ruzzante, A. Salvi, F. Semplici, R. Longhi, et al. 1997. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat. Med. 3:1250.
13. Schulz, M., R. M. Zinkernagel, and H. Hengartner. 1991. Peptide-induced anti-viral protection by cytotoxic T cells. Proc. Natl. Acad. Sci. USA 88:991.
14. Kast, W. M., L. Roux, J. Curren, H. J. Blom, A. C. Voordouw, R. H. Meloen, D. Kolakofsky, and C. J. Melief. 1991. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. Proc. Natl. Acad. Sci. USA 88:2283.
15. Vitiello, A., D. Marchesini, J. Furze, L. A. Sherman, and R. W. Chesnut. 1991. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex. J. Exp. Med. 173:1007.
16. Schild, H., M. Norda, K. Deres, K. Falk, O. Rotzschke, K. H. Wiesmuller, G. Jung, and H. G. Rammensee. 1991. Fine specificity of cytotoxic T lymphocytes primed in vivo either with virus or synthetic lipopeptidc vaccine or primed in vitro with peptide. J. Exp. Med. 174:1665.
17. Alexander, J., J. Sidney, S. Southwood, I. Ruppert, C. Oseroff, A. Maewal, K. Snoke, H. M. Serra, R. T. Kubo, and A. Sette. 1994. Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. Immunity 1:751.
18. Vitiello, A., G. Ishioka, H. M. Grey, R. Rose, P. Farness, R. LaFond, L. Yuan, F. V. Chisari, J. Furze, and R. Bartholomeuz. 1995. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans. J. Clin. Invest. 95:341.
19. Sinigaglia, F., M. Guttinger, J. Kilgus, D. M. Doran, H. Matile, H. Etlinger, A. Trzeciak, D. Gillessen, and J. R. Pink. 1988. A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules. Nature 336:778.
20. Busch, R., G. Strang, K. Howland, and J. B. Rothbard. 1990. Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces. Int. Immunol. 2:443.
21. Geluk, A., K. E. Van Meijgaarden, J. W. Drijfhout, and T. H. Ottenhoff. 1995. Clip binds to HLA class II using methionine-based. allele-dependent motifs as well as allele-independent supermotifs. Mol. Immunol. 32:975.
22. Ossendorp, F., E. Mengede, M. Camps, R. Filius, and C. J. M. Melief. 1998. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors. J. Exp. Med. 187:1.
23. + T cell help. J. Exp. Med. 186:65.
24. Keene, J. A., and J. Forman. 1982. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J. Exp. Med. 155:768.
25. Schoenberger, S. P., R. E. Toes, E. I. van der Voort, R. Offringa, and C. J. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480.
26. Layne, S. P., M. J. Merges, M. Dembo, J. L. Spouge, S. R. Conley, J. P. Moore, J. L. Raina, H. Renz, H. R. Gelderblom, and P. L. Nara. 1992. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Virology 189:695.
27. Walker, B. D., C. Flexner, T. J. Paradis, T. C. Fuller, M. S. Hirsch, R. T. Schooley, and B. Moss. 1988. HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. Science 240:64.
28. Hosmalin, A., M. Clerici, R. Houghten, C. D. Pendleton, C. Flexner, D. R. Lucey, B. Moss, R. N. Germain, G. M. Shearer, and J. A. Berzofsky. 1990. An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 87:2344.
29. van der Burg, S. H., M. R. Klein, C. J. H. van de Velde, W. M. Kast, F. Miedema, and C. J. M. Melief. 1995. Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase. AIDS 9:121.
30. De Groot, A. S., M. Clerici, A. Hosmalin, S. H. Hughes, D. Barnd, C. W. Hendrix, R. Houghten, G. M. Shearer, and J. A. Berzofsky. 1991. Human immunodeficiency virus reverse transcriptase T helper epitopes identified in mice and humans: correlation with a cytotoxic T cell epitope. J. Infect. Dis. 164:1058.
31. Manca, F., D. Fenoglio, M. T. Valle, G. Li Pira, A. Kunkl, R. S. Balderas, R. G. Baccala, D. H. Kono, A. Ferraris, D. Saverino, et al. 1995. Human T helper cells specific for HIV reverse transcriptase: possible role in intrastructural help for HIV envelope-specific antibodies. Eur. J. Immunol. 25:1217.
32. Tanese, N., V. R. Prasad, and S. P. Goff. 1988. Structural requirements for bacterial expression of stable, enzymatically active fusion proteins containing the human immunodeficiency virus reverse transcriptase. DNA 7:407.
33. Studier, F. W., A. H. Rosenberg, J. J. Dunn, and J. W. Dubendorff. 1990. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 185:60.
34. De Bruijn, M. L., D. H. Schuurhuis, M. P. Vierboom, H. Vermeulen, K. A. de Cock, M. E. Ooms, M. E. Ressing, M. Toebes, K. L. Franken, J. W. Drijfhout, et al. 1998. Immunization with human papillomavirus type 16 (HPV 16) oncoprotein-loaded dendritic cells as well as protein in adjuvant induces MHC class I-restricted protection to HPV16-induced tumor cells. Cancer Res. 58:724.
35. Ottenhoff, T. H., A. Geluk, M. Toebes, W. E. Benckhuijsen, K. E. Van Meijgaarden, and J. W. Drijfhout. 1997. A sensitive fluorometric assay for quantitatively measuring specific peptide binding to HLA class I and class II molecules. J. Immunol. Methods 200:89.
36. Posch, P. E., C. K. Hurley, A. Geluk, and T. H. Ottenhoff. 1996. The impact of DR3 microvariation on peptide binding: the combinations of specific DR β residues critical to binding differ for different peptides. Hum. Immunol. 49:96.
37. ten Bosch, G. J. A., A. C. Toornvliet, T. Friede, C. J. M. Melief, and O. C. Leeksma. 1995. Recognition of peptides corresponding to the joining region of p210 BCR-ABL protein by human T cells. Leukemia 9:1344.
38. De Fijter, J. W., M. R. Daha, W. E. M. Schroeiers, L. A. van Es, and C. van Kooten. 1998. Increased IL-10 production by stimulated whole blood cultures in primary 1gA nephropathy. Clin. Exp. Immunol. 111:429.
39. Baur, M. P., M. Neugebauer, and H. Deppe. 1904. Population analysis on the basis of deduced haplotypes from random families. In Histocompatibility Testing, 1st Ed. E. D. Albert, M. P. Baur, and W. R. Mayr, eds. Springer-Verlag. Berlin, pp. 333-341.
40. Korbel, B., R. Koup, B. Walker, B. Haynes, J. Moore, and G. Myers, eds. 1995. HIV Molecular Immunological Database. Theoretical Biology and Biophysics Group, Los Alamos.
41. Wakefield, J. K., S. A. Jablonski, and C. D. Morrow. 1992. In vitro enzymatic activity of human immunodeficiency virus type 1 reverse transcriptase mutants in the highly conserved YMDD amino acid motif correlates with the infectious potential of the proviral genome. J. Virol. 66:6806.
42. Rudensky, A. Y., P. Preston-Hurlburt, S. C. Hong, A. Barlow, and C. A. Janeway, Jr. 1991. Sequence analysis of peptides bound to MHC class II molecules. Nature 353:622.
43. Nelson, C. A., S. J. Petzold, and E. R. Unanue. 1993. Identification of two distinct properties of class II major histocompatibility complex-associated peptides. Proc. Natl. Acad. Sci. USA 90:1227.
44. Manca, F., J. Habeshaw, and A. Dalgleish. 1991. The naive repertoire of human T helper cells specific for gp120, the envelope glycoprotein of HIV. J. Immunol. 146:1964.
45. + T cells can discriminate the molecular and structural context of T epitopes of HIV gp120 and HIV p66. J. Acquired Immune Def. Syndromes Hum. Retrovirol. 9:227.
46. Pakker, N. G., D. W. Notermans, R. J. de Boer, M. T. Roos, F. de Wolf, A. Hill, J. M. Leonard, S. A. Danner, F. Miedema, and P. T. Schellekens. 1998. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat. Med. 4:208.
47. Finzi, D., M. Hermankova, T. Pierson, L. M. Carruth, C. Buck, R. E. Chaisson, T. C. Quinn, K. Chadwick, J. Margolick, R. Brookmeyer, et al. 1997. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278:1295.